Back to search
FDAFDA · Food and drugs·Recall number Z-2580-2026

Intera Oncology INTERA 3000 Hepatic Artery Infusion Pump, AP-0300H, implantable drug delivery device

Published July 1, 2026 · Recall initiated: May 11, 2026

Summary

FDA records medical device Class II recall Z-2580-2026, published July 1, 2026 and initiated May 11, 2026. Recalling firm: Boston Scientific Corporation; Status: Completed; Reported quantity: 1 device; Lot: GTIN 00850014110147, Serial Number 20175. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

There is the potential for leakage along the drug pathway from the pump through the end of the catheter.

What to do

Voluntary: Firm initiated · Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Boston Scientific Corporation
Distributor
US Nationwide distribution in the state of OH.
Lot
GTIN 00850014110147, Serial Number 20175
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Intera Oncology INTERA 3000 Hepatic Artery Infusion Pump, AP-0300H, implantable drug delivery device recalled?

Yes. FDA published recall Z-2580-2026 on July 1, 2026. Reported hazard: There is the potential for leakage along the drug pathway from the pump through the end of the catheter.

What should I do if I have this product?

Voluntary: Firm initiated · Visit